Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
Gesundheit & MedizinOne-Off1J
Manifold MarketsKein KYCVerifizierte AuflösungsdatenGut kalibriertAktuelle Community-PrognoseNein 64.9%
Prognostiker
8
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 16 Stunden
Veraltet21. Feb. 23, 20:21 UTC31. Dez. 27, 22:59 UTC
Trends
Regeln
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of squamous cell carcinoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
